AbbVie

Yesterday

How AbbVie's Pipeline Is Lining Up Key Product Launches Zacks15:06 16-Dec-25

In the last 7 days

AbbVie (ABBV) Gains As Market Dips: What You Should Know Zacks23:50 15-Dec-25

AbbVie’s (ABBV) Options Flow Implies That the Smart Money Could Be Up to Something Barchart18:40 15-Dec-25

RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells PR Newswire (Press Release)12:03 15-Dec-25

AbbVie Ranked #15 in the Inaugural Fortune 100 Best Companies to Work For Southeast Asia 2025 List The Hindu Business Line10:12 15-Dec-25

AbbVie’s New Study on Parkinson’s Treatment: What Investors Need to Know TipRanks16:40 14-Dec-25

AbbVie’s Pediatric Kidney Disease Study Update: Implications for Investors TipRanks16:40 14-Dec-25

AbbVie’s Venetoclax Study for AML: Key Insights for Investors TipRanks16:40 14-Dec-25

AbbVie Slipped Below 50-Day SMA Last Week: How to Play the Stock Zacks13:46 12-Dec-25

Is AbbVie Stock Too Cheap to Ignore at Today's Price? The Motley Fool16:40 11-Dec-25

Botox parent AbbVie hopes to reclaim lost market share The State, South Carolina15:03 11-Dec-25

Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth Zacks13:56 11-Dec-25

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen,… 24/7 Wall St.13:25 10-Dec-25

HSBC highlights one pharma stock to buy and one to sell for 2026 Investing.com13:15 10-Dec-25

This AbbVie Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday Benzinga12:37 10-Dec-25

In the last month

AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks23:45 8-Dec-25

Ose Immunotherapeutics stock falls after AbbVie deal amendment Investing.com13:25 8-Dec-25

AbbVie revs up Skyrizi spending to top TV ad totals in November, edging out J&J’s Tremfya FiercePharma19:08 5-Dec-25

Could Buying AbbVie Today Set You Up for Life? The Motley Fool14:37 4-Dec-25

How Strong Is AbbVie's Immunology Franchise After Humira's LOE? Zacks13:47 4-Dec-25

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know Zacks15:01 3-Dec-25

AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment… PR Newswire (Press Release)13:20 2-Dec-25

AbbVie reports Phase III study results of atogepant Clinical Trials Arena11:21 2-Dec-25

AbbVie’s atogepant illustrates migraine therapy label expansion potential European Pharmaceutical Review14:46 1-Dec-25

AbbVie to Present Phase 3 ECLIPSE Data Demonstrating Atogepant (AQUIPTA®) Superiority Over… PR Newswire (Press Release)09:09 1-Dec-25

AbbVie Scores Canadian Reimbursement Recommendations For Blockbuster Ulcerative Colitis Drug Skyrizi Benzinga16:24 28-Nov-25

Global Pharma company with big site in Mayo scoop industry awards The Mayo News16:40 27-Nov-25

BioMed X announces neuroscience research partnership with AbbVie Manufacturing Chemist09:48 27-Nov-25

AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights Zacks16:49 26-Nov-25

Is AbbVie Stock Outperforming the Nasdaq? Barchart15:12 26-Nov-25

AbbVie short film showcases ‘Second Winds’ of life after CLL diagnosis FiercePharma17:50 25-Nov-25

BioMed X Announces New Neuroscience Research Collaboration in the USA Biotech, B3C newswire05:11 25-Nov-25

AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference PR Newswire (Press Release)13:01 24-Nov-25

The Zacks Analyst Blog JPMorgan, Netflix, AbbVie and Ohio Valley Banc Zacks11:17 24-Nov-25

Assessing AbbVie’s Share Value After Stock Climbs 31.7% in 2025 Simply Wall St03:04 24-Nov-25

FDA Approval of EPKINLY Combo Might Change the Case for Investing in AbbVie (ABBV) Simply Wall St08:00 22-Nov-25

Top Research Reports for JPMorgan Chase, Netflix & AbbVie Zacks22:27 21-Nov-25

2 Dividend Stocks to Hold Through Any Market Cycle 24/7 Wall St.17:32 19-Nov-25

Vitiligo Market Analysis and Forecasts 2025-2035 Featuring Abbvie, Incyte, Amgen, Pfizer,… Business Wire (Press Release)16:29 19-Nov-25

AbbVie Stock Rebounds After Q3 Dip: Time to Buy, Hold or Sell? Zacks15:12 19-Nov-25

AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Zacks15:02 19-Nov-25

FDA approves AbbVie’s Epkinly to treat follicular lymphoma Pharmaceutical Technology14:45 19-Nov-25

Approvals extend use of Roche, AbbVie drugs in lymphoma pharmaphorum11:23 19-Nov-25

FDA Greenlights AbbVie And Genmab's Epkinly Combo For Relapsed Or Refractory Follicular Lymphoma RTT News09:09 19-Nov-25

AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for… AbbVie (Press Release)17:49 18-Nov-25

Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3 Zacks15:44 18-Nov-25

AbbVie parts ways with Calico Longevity Technology13:37 17-Nov-25

AbbVie Stock Falls 4% -- What Investors Need to Know The Motley Fool12:53 17-Nov-25

Filmmaker helps AbbVie spread the word about leukaemia pharmaphorum12:27 17-Nov-25

view more headlines

16 Dec 15:06

AbbVie News

NewsNow aims to be the world's most accurate and comprehensive aggregator of AbbVie news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.